Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert C. Gay currently holds 5,297 shares of MERRIMACK PHARMACEUTICALS INC (MACK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert C. Gay has been a net neutral trader of MACK stock. They have purchased $0 and sold $0 worth of shares.
Robert C. Gay's most recent insider trade was on May 22, 2026, when they sold 5,296 shares at $0.00 per share.
Robert C. Gay serves as Executive at MERRIMACK PHARMACEUTICALS INC (MACK). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Robert C. Gay holds the position of Executive at MERRIMACK PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Robert C. Gay has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Robert C. Gay was on May 22, 2026, when they sold $0 worth of ANGX shares. This transaction involved 5,296 shares at N/A per share.
Robert C. Gay currently owns 5,297 shares of MERRIMACK PHARMACEUTICALS INC (MACK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert C. Gay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert C. Gay has 6 Form 4 filings on record as an insider at MERRIMACK PHARMACEUTICALS INC.
Set alerts for Robert C. Gay and 40,000+ other insiders.